<html>
<head>PUBMED IDs for MARVELD1</head>
<body bgcolor='#C5F0F2'><h1>MARVELD1</h1><a href='https://pubmed.ncbi.nlm.nih.gov/19364627/'>Identification and characterization of MARVELD1, a novel nuclear protein that is down-regulated in multiple cancers and silenced by DNA methylation.</a> August 1  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/22320884/'>MARVELD1 inhibited cell proliferation and enhance chemosensitivity via increasing expression of p53 and p16 in hepatocellular carcinoma.</a> May 17  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/24055813/'>MARVELD1 regulates integrin β1-mediated cell adhesion and actin organization via inhibiting its pre-mRNA processing.</a> August 29  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/25299200/'>Identifying differential expression genes and single nucleotide variations using RNA-seq in metastatic melanoma.</a> June 24  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25520033/'>Biological and clinical significance of epigenetic silencing of MARVELD1 gene in lung cancer.</a> October 1  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/26107903/'>[Importin-β1 plays a key role in the nucleocytoplasmic transportation process of MARVELD1].</a> August 15  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26509557/'>MARVELD1 modulates cell surface morphology and suppresses epithelial-mesenchymal transition in non-small cell lung cancer.</a> October 29  2015<br></body></html>
